Quit4U: the Effectiveness of Combining Behavioural Support, Pharmacotherapy and Financial Incentives To Support Smoking Cessation

R Ormston; M van der Pol; A Ludbrook; S McConville; A Amos

doi:10.1093/her/cyu024

Quit4U: the Effectiveness of Combining Behavioural Support, Pharmacotherapy and Financial Incentives To Support Smoking Cessation

R Ormston, M van der Pol, A Ludbrook, S McConville, A Amos

University of Edinburgh

Research output: Contribution to journal › Article › peer-review

15 Citations (Scopus)

Abstract

The 'quit4u' stop smoking service (SSS) was developed by National Health Service (NHS) Tayside for smokers in deprived areas of Dundee (UK). quit4u combined behavioural support and pharmacotherapy with financial incentives for each week that participants remained quit. A quasi-experimental study was undertaken with smokers using quit4u between 2009 and 2011 compared with smokers using SSSs in the rest of Scotland. The outcome measures were: number of quit attempts; quit rates at 1, 3 and 12 months; cost-effectiveness. Mechanisms of change were explored through quantitative and qualitative research that explored the views and experiences of service users and professionals involved in quit4u. The number of quit attempts made using SSSs in deprived areas of NHS Tayside increased by 44% between 2007 and 2010. quit4u had significantly higher quit rates at 1 month (49.9% versus 33.7%), 3 months (30.7% versus 14.2%) and 12 months (9.3% versus 6.5%) compared with similar smokers using other SSSs. The incremental cost per quitter was £2296. A combination of elements kept clients engaged and supported quit attempts: carbon monoxide (CO) tests, financial incentives, high-quality pharmacy support, rolling groups and greater varenicline use. quit4u may provide an effective and cost-effective model for engaging and supporting smokers in deprived areas to quit.

Original language	English
Pages (from-to)	121-133
Number of pages	13
Journal	Health Education Research
Volume	30
Issue number	1
Early online date	21 May 2014
DOIs	https://doi.org/10.1093/her/cyu024
Publication status	Published - Feb 2015

Bibliographical note

Acknowledgements
The authors thank all those involved in quit4u-NHS Tayside, partners and participants. The authors particularly like to thank Fiona Myers (NHS Health Scotland), Andrew Radley (NHS Tayside), Paul Ballard (NHS Tayside) and Linsey Galbraith (ISD).

Funding
This work was supported by NHS Health Scotland. The Chief Scientist Office of the Scottish Government Health Directorates funds HERU. The opinions expressed in this paper are those of the authors and are not necessarily those of the NHS Health Scotland.

Keywords

Smoking
Pharmacotherapy
Smoking Cessation
Cost effectiveness
Pharmacies
Scotland
Staphylococcal scalded skin syndrome
Behavior
Incentives
Varenicline
Financial Incentives
Clients
National Health Service (UK)

Access to Document

10.1093/her/cyu024Licence: Unspecified

http://www.ncbi.nlm.nih.gov/pubmed/24848555

Cite this

@article{c624842bc37d499594c8d88e7e255797,

title = "Quit4U: the Effectiveness of Combining Behavioural Support, Pharmacotherapy and Financial Incentives To Support Smoking Cessation",

abstract = "The 'quit4u' stop smoking service (SSS) was developed by National Health Service (NHS) Tayside for smokers in deprived areas of Dundee (UK). quit4u combined behavioural support and pharmacotherapy with financial incentives for each week that participants remained quit. A quasi-experimental study was undertaken with smokers using quit4u between 2009 and 2011 compared with smokers using SSSs in the rest of Scotland. The outcome measures were: number of quit attempts; quit rates at 1, 3 and 12 months; cost-effectiveness. Mechanisms of change were explored through quantitative and qualitative research that explored the views and experiences of service users and professionals involved in quit4u. The number of quit attempts made using SSSs in deprived areas of NHS Tayside increased by 44% between 2007 and 2010. quit4u had significantly higher quit rates at 1 month (49.9% versus 33.7%), 3 months (30.7% versus 14.2%) and 12 months (9.3% versus 6.5%) compared with similar smokers using other SSSs. The incremental cost per quitter was £2296. A combination of elements kept clients engaged and supported quit attempts: carbon monoxide (CO) tests, financial incentives, high-quality pharmacy support, rolling groups and greater varenicline use. quit4u may provide an effective and cost-effective model for engaging and supporting smokers in deprived areas to quit.",

keywords = "Smoking, Pharmacotherapy, Smoking Cessation, Cost effectiveness, Pharmacies, Scotland, Staphylococcal scalded skin syndrome, Behavior, Incentives, Varenicline, Financial Incentives, Clients, National Health Service (UK)",

author = "R Ormston and {van der Pol}, M and A Ludbrook and S McConville and A Amos",

note = "Acknowledgements The authors thank all those involved in quit4u-NHS Tayside, partners and participants. The authors particularly like to thank Fiona Myers (NHS Health Scotland), Andrew Radley (NHS Tayside), Paul Ballard (NHS Tayside) and Linsey Galbraith (ISD). Funding This work was supported by NHS Health Scotland. The Chief Scientist Office of the Scottish Government Health Directorates funds HERU. The opinions expressed in this paper are those of the authors and are not necessarily those of the NHS Health Scotland.",

year = "2015",

month = feb,

doi = "10.1093/her/cyu024",

language = "English",

volume = "30",

pages = "121--133",

journal = "Health Education Research",

issn = "0268-1153",

publisher = "Oxford University Press",

number = "1",

}

TY - JOUR

T1 - Quit4U

T2 - the Effectiveness of Combining Behavioural Support, Pharmacotherapy and Financial Incentives To Support Smoking Cessation

AU - Ormston, R

AU - van der Pol, M

AU - Ludbrook, A

AU - McConville, S

AU - Amos, A

N1 - Acknowledgements The authors thank all those involved in quit4u-NHS Tayside, partners and participants. The authors particularly like to thank Fiona Myers (NHS Health Scotland), Andrew Radley (NHS Tayside), Paul Ballard (NHS Tayside) and Linsey Galbraith (ISD). Funding This work was supported by NHS Health Scotland. The Chief Scientist Office of the Scottish Government Health Directorates funds HERU. The opinions expressed in this paper are those of the authors and are not necessarily those of the NHS Health Scotland.

PY - 2015/2

Y1 - 2015/2

N2 - The 'quit4u' stop smoking service (SSS) was developed by National Health Service (NHS) Tayside for smokers in deprived areas of Dundee (UK). quit4u combined behavioural support and pharmacotherapy with financial incentives for each week that participants remained quit. A quasi-experimental study was undertaken with smokers using quit4u between 2009 and 2011 compared with smokers using SSSs in the rest of Scotland. The outcome measures were: number of quit attempts; quit rates at 1, 3 and 12 months; cost-effectiveness. Mechanisms of change were explored through quantitative and qualitative research that explored the views and experiences of service users and professionals involved in quit4u. The number of quit attempts made using SSSs in deprived areas of NHS Tayside increased by 44% between 2007 and 2010. quit4u had significantly higher quit rates at 1 month (49.9% versus 33.7%), 3 months (30.7% versus 14.2%) and 12 months (9.3% versus 6.5%) compared with similar smokers using other SSSs. The incremental cost per quitter was £2296. A combination of elements kept clients engaged and supported quit attempts: carbon monoxide (CO) tests, financial incentives, high-quality pharmacy support, rolling groups and greater varenicline use. quit4u may provide an effective and cost-effective model for engaging and supporting smokers in deprived areas to quit.

AB - The 'quit4u' stop smoking service (SSS) was developed by National Health Service (NHS) Tayside for smokers in deprived areas of Dundee (UK). quit4u combined behavioural support and pharmacotherapy with financial incentives for each week that participants remained quit. A quasi-experimental study was undertaken with smokers using quit4u between 2009 and 2011 compared with smokers using SSSs in the rest of Scotland. The outcome measures were: number of quit attempts; quit rates at 1, 3 and 12 months; cost-effectiveness. Mechanisms of change were explored through quantitative and qualitative research that explored the views and experiences of service users and professionals involved in quit4u. The number of quit attempts made using SSSs in deprived areas of NHS Tayside increased by 44% between 2007 and 2010. quit4u had significantly higher quit rates at 1 month (49.9% versus 33.7%), 3 months (30.7% versus 14.2%) and 12 months (9.3% versus 6.5%) compared with similar smokers using other SSSs. The incremental cost per quitter was £2296. A combination of elements kept clients engaged and supported quit attempts: carbon monoxide (CO) tests, financial incentives, high-quality pharmacy support, rolling groups and greater varenicline use. quit4u may provide an effective and cost-effective model for engaging and supporting smokers in deprived areas to quit.

KW - Smoking

KW - Pharmacotherapy

KW - Smoking Cessation

KW - Cost effectiveness

KW - Pharmacies

KW - Scotland

KW - Staphylococcal scalded skin syndrome

KW - Behavior

KW - Incentives

KW - Varenicline

KW - Financial Incentives

KW - Clients

KW - National Health Service (UK)

U2 - 10.1093/her/cyu024

DO - 10.1093/her/cyu024

M3 - Article

C2 - 24848555

SN - 0268-1153

VL - 30

SP - 121

EP - 133

JO - Health Education Research

JF - Health Education Research

IS - 1

ER -

Quit4U: the Effectiveness of Combining Behavioural Support, Pharmacotherapy and Financial Incentives To Support Smoking Cessation

Abstract

Bibliographical note

Keywords

Access to Document

Fingerprint

Cite this